Status:
UNKNOWN
Outcomes of Acute Myeloid Leukemia Patients
Lead Sponsor:
Assiut University
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18-70 years
Brief Summary
1. To assess overall survival of AML patient. 2. To measure rate of disease free survival. 3. rate of non relapse mortality. 4. rate of complete remission . 5. percentage of refractory disease. 6. per...
Detailed Description
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is characterized by malignant clonal expansion and differentiation arrest of myeloid progenitor cells. The etiology of AM...
Eligibility Criteria
Inclusion
- AML patients, aged more than 18yrs and received chemotherapy (aggressive or palliative).
Exclusion
- patients less than 18years old.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04392310
Start Date
June 1 2020
End Date
November 1 2020
Last Update
May 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.